Structural brain abnormality, pharmacotherapy, and treatment resistant schizophrenia management: a systematic review and critical appraisal
Expert Opin Pharmacother. 2026 Nov 15. doi: 10.1080/14656566.2026.2763331. Online ahead of print.ABSTRACTINTRODUCTION: Treatment-resistant schizophrenia (TRS) affects up to 30% of patients with schizophrenia and carries...
